Adaptive Liquid Crystal Windows

Energy consumption by private and commercial sectors in the U.S. has steadily grown over the last decade. The uncertainty in future availability of imported oil, on which the energy consumption relies strongly, resulted in a dramatic increase in the cost of energy. About 20% of this consumption are used to heat and cool houses and commercial buildings. To reduce dependence on the foreign oil and cut down emission of greenhouse gases, it is necessary to eliminate losses and reduce total energy consumption by buildings. To achieve this goal it is necessary to redefine the role of the conventional windows. At a minimum, windows should stop being a source for energy loss. Ideally, windows should become a source of energy, providing net gain to reduce energy used to heat and cool homes. It is possible to have a net energy gain from a window if its light transmission can be dynamically altered, ideally electronically without the need of operator assistance, providing optimal control of the solar gain that varies with season and climate in the U.S. In addition, the window must not require power from the building for operation. Resolution of this problem is a societal challenge and of national interest and will have a broad global impact. For this purpose, the year-round, allclimate window solution to provide an electronically variable solar heat gain coefficient (SHGC) with a wide dynamic range is needed. AlphaMicron, Inc. (AMI) developed and manufactured 1ft × 1ft prototype panels for the world’s first auto-adjusting Adaptive Liquid Crystal Windows (ALCWs) that can operate from sunlight without the need for external power source and demonstrate an electronically adjustable SHGC. This novel windows are based on AlphaMicron’s patented e-Tint® technology, a guesthost liquid crystal system implemented on flexible, optically clear plastic films. This technology is suitable both for OEM and aftermarket (retro-fitting) lamination to new and existing windows. Low level of power consumption by ALCWs allows for on-board power electronics for automatic matching of transmission through windows to varying climate conditions without drawing the power from the power grid. ALCWs are capable of transmitting more sunlight in winters to assist in heating and less sunlight in summers to minimize overheating. As such, they can change the window from being a source of energy loss to a source of energy gain. In addition, the scalable AMI’s roll-to-roll process, proved by making 1ft × 1ftALCW prototype panels, allows for cost-effective production of large-scale window panels along with capability to change easily their color and shape. In addition to architectural glazing in houses and commercial buildings, ALCWs can be used in other applications where control of sunlight is needed, such as green houses, used by commercial produce growers and botanical gardens, cars, aircrafts, etc

Effects of structure and composition of lead glasses on thermal lensing

Physic

Adaptive Liquid Crystal Windows

Energy consumption by private and commercial sectors in the U.S. has steadily grown over the last decade. The uncertainty in future availability of imported oil, on which the energy consumption relies strongly, resulted in a dramatic increase in the cost of energy. About 20% of this consumption are used to heat and cool houses and commercial buildings. To reduce dependence on the foreign oil and cut down emission of greenhouse gases, it is necessary to eliminate losses and reduce total energy consumption by buildings. To achieve this goal it is necessary to redefine the role of the conventional windows. At a minimum, windows should stop being a source for energy loss. Ideally, windows should become a source of energy, providing net gain to reduce energy used to heat and cool homes. It is possible to have a net energy gain from a window if its light transmission can be dynamically altered, ideally electronically without the need of operator assistance, providing optimal control of the solar gain that varies with season and climate in the U.S. In addition, the window must not require power from the building for operation. Resolution of this problem is a societal challenge and of national interest and will have a broad global impact. For this purpose, the year-round, allclimate window solution to provide an electronically variable solar heat gain coefficient (SHGC) with a wide dynamic range is needed. AlphaMicron, Inc. (AMI) developed and manufactured 1ft × 1ft prototype panels for the world’s first auto-adjusting Adaptive Liquid Crystal Windows (ALCWs) that can operate from sunlight without the need for external power source and demonstrate an electronically adjustable SHGC. This novel windows are based on AlphaMicron’s patented e-Tint® technology, a guesthost liquid crystal system implemented on flexible, optically clear plastic films. This technology is suitable both for OEM and aftermarket (retro-fitting) lamination to new and existing windows. Low level of power consumption by ALCWs allows for on-board power electronics for automatic matching of transmission through windows to varying climate conditions without drawing the power from the power grid. ALCWs are capable of transmitting more sunlight in winters to assist in heating and less sunlight in summers to minimize overheating. As such, they can change the window from being a source of energy loss to a source of energy gain. In addition, the scalable AMI’s roll-to-roll process, proved by making 1ft × 1ftALCW prototype panels, allows for cost-effective production of large-scale window panels along with capability to change easily their color and shape. In addition to architectural glazing in houses and commercial buildings, ALCWs can be used in other applications where control of sunlight is needed, such as green houses, used by commercial produce growers and botanical gardens, cars, aircrafts, etc

Enhancement in Electro-Optic Properties of Dynamic Scattering Systems through Addition of Dichroic Dyes

Electro-optic properties of dynamic scattering in homeotropically aligned pure and dichroic dye-doped nematic liquid crystal samples are examined. The optical properties of the two systems are quantified using transmission properties of scattered and unscattered as a function of amplitude and frequency of an applied voltage. Auto-correlation of the scattered signal at different applied voltages is used to compare the decay times in the two systems. Lastly, the histogram of the scattered signal reveals a wavevector dependent large light scattering event. The dye-doped system shows a significant enhancement of light blocking property in both normal and off-axis light propagation. The characteristics of the system are compared to other scattering technologies. The results suggest that dye-doped system can overcome shortcomings in scattering based devices used for near-eye applications

A Survey on the Effects of Gold-Nanoparticles in Allergic Asthma

Background and Aim: Asthma is an inflammatory airway disease and allergies are the most important cause of asthma. Different types of drugs have been developed to control asthma, and the use of carrier systems to transfer drugs to the airways is an effective method. Gold nanoparticles (AuNP) is a subject of substantial research that can be easily synthesized and, in this study, the effect of gold nanoparticles on allergic asthma was evaluated. Methods: There are 4 groups of mice, including: the control group, the control group receiving AuNPs, the asthmatic group, and the asthmatic group receiving AuNPs. An animal model of asthma was produced using ovalbumin (OVA). The negative control group was sensitized and challenged with PBS. Broncho-alveolar lavage fluid (BALF) and lung tissue were collected, then quantitative real-time PCR for the four target genes (IL-4, IL-5, IL-13, and MUC5ac) and histopathological study of lung tissue was done. Results: In the OVA group, the mRNA expression of targeted genes had no significant differences (P>0.05). Mucus hypersecretion, goblet cell hyperplasia, peribronchial and perivascular inflammation had no significant difference between AuNPs receiving groups with non-treated groups (P>0.05). Conclusion: In this study, it was observed that AuNP did not affect asthma and control mice. These nanoparticles did not elicit any immune or allergic responses and can be easily used for therapeutic or diagnostic purposes. *Corresponding Authors: Alireza Taheri; Email: [email protected]; Seyyed Shamsadin Athari, Email: [email protected] Please cite this article as: Mehrabi Nasab D, Taheri A, Jafari B, Athari SS. A Survey on the Effects of Gold-Nanoparticles in Allergic Asthma. Arch Med Lab Sci. 2021;7:1-5 (e21). https://doi.org/10.22037/amls.v6.3276

Back to the Individual-Social Life in patient with Avascular necrosis of femur by Bioresonance Technology (Case Report)

Background: More than 20,000 people annually develop avascular necrosis (AVN) worldwide, most of whom aged 20 to 50 years, and should refer to orthopedic surgeons for treatment. The quality of life of such patients is low due to chronic pain and sometimes they are deprived of their occupation and social life. Case Report: A 57-year-old male patient who developed AVN due to long-term treatment with corticosteroids and their complications was significantly recovered following EPT therapy in a three-year follow-up. Regarding the correlation between chronic diseases and SDH, to treat such patients, improve their quality of life, and help them back normal life, safe complementary therapies, such as bioresonance, are recommended. &nbsp

INTESTINAL HELMINTHS FROM THE VIEWPOINT OF TRADITIONAL PERSIAN MEDICINE VERSUS MODERN MEDICINE

Background: Traditional Persian Medicine (TPM) has a history of almost 10,000 years with practice and experience aspects. The existing information and experiences of physicians such as Avicenna clearly show the vast amount of knowledge in the classification and treatment of pathogenic worms. The aim of this paper was the description of the various types of helminths along with their treatment in medieval Persia and comparing them with new medical findings. Materials and Methods: We searched main Traditional Persian Medical and pharmacological texts about etiology, manifestation, diagnosis and treatment of worms in the human digestive system and the out come was compared with the data extracted from modern medical sources. A list of medicinal plants was also extracted from traditional pharmacological books and the anthelmintic properties of these plants were checked in Google Scholar, Scopus, PubMed and Ulrich's databases. Results: The results show the existence of theories on pathogenicity, physiopathology, symptoms and the classification of worms in TPM. TPM philosophers have divided worms into four groups and there is not great difference between old Persian and Modern classification. The old Persian scholars have explained a treatment procedure using a list of 48 medicinal plants and the anthelmintic effect of 23 plants have been shown in modern medicine studies. Conclusion: This study shows a more in-depth and thorough classification of pathogenic worms, their pathogenicity, symptoms and treatments in Traditional Persian Medical compared to Greek Medicine so that old Persian classification may be the base of modern taxonomy. More clinical trials are suggested for the efficacy and safety of these plants

The global burden of adolescent and young adult cancer in 2019 : a systematic analysis for the Global Burden of Disease Study 2019

Background In estimating the global burden of cancer, adolescents and young adults with cancer are often overlooked, despite being a distinct subgroup with unique epidemiology, clinical care needs, and societal impact. Comprehensive estimates of the global cancer burden in adolescents and young adults (aged 15-39 years) are lacking. To address this gap, we analysed results from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019, with a focus on the outcome of disability-adjusted life-years (DALYs), to inform global cancer control measures in adolescents and young adults. Methods Using the GBD 2019 methodology, international mortality data were collected from vital registration systems, verbal autopsies, and population-based cancer registry inputs modelled with mortality-to-incidence ratios (MIRs). Incidence was computed with mortality estimates and corresponding MIRs. Prevalence estimates were calculated using modelled survival and multiplied by disability weights to obtain years lived with disability (YLDs). Years of life lost (YLLs) were calculated as age-specific cancer deaths multiplied by the standard life expectancy at the age of death. The main outcome was DALYs (the sum of YLLs and YLDs). Estimates were presented globally and by Socio-demographic Index (SDI) quintiles (countries ranked and divided into five equal SDI groups), and all estimates were presented with corresponding 95% uncertainty intervals (UIs). For this analysis, we used the age range of 15-39 years to define adolescents and young adults. Findings There were 1.19 million (95% UI 1.11-1.28) incident cancer cases and 396 000 (370 000-425 000) deaths due to cancer among people aged 15-39 years worldwide in 2019. The highest age-standardised incidence rates occurred in high SDI (59.6 [54.5-65.7] per 100 000 person-years) and high-middle SDI countries (53.2 [48.8-57.9] per 100 000 person-years), while the highest age-standardised mortality rates were in low-middle SDI (14.2 [12.9-15.6] per 100 000 person-years) and middle SDI (13.6 [12.6-14.8] per 100 000 person-years) countries. In 2019, adolescent and young adult cancers contributed 23.5 million (21.9-25.2) DALYs to the global burden of disease, of which 2.7% (1.9-3.6) came from YLDs and 97.3% (96.4-98.1) from YLLs. Cancer was the fourth leading cause of death and tenth leading cause of DALYs in adolescents and young adults globally. Interpretation Adolescent and young adult cancers contributed substantially to the overall adolescent and young adult disease burden globally in 2019. These results provide new insights into the distribution and magnitude of the adolescent and young adult cancer burden around the world. With notable differences observed across SDI settings, these estimates can inform global and country-level cancer control efforts. Copyright (C) 2021 The Author(s). Published by Elsevier Ltd.Peer reviewe